Scott Sudduth
Chief Tech/Sci/R&D Officer chez COLLEGIUM PHARMACEUTICAL, INC.
Profil
Scott Sudduth is currently the Executive Vice President-Technical Operations at Collegium Pharmaceutical, Inc. He previously worked as the Vice President at Genzyme Corp.
and as the Head-Supply Chain at Moderna, Inc. Mr. Sudduth completed his undergraduate degree at Clarkson University.
Postes actifs de Scott Sudduth
| Sociétés | Poste | Début |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Chief Tech/Sci/R&D Officer | 01/10/2021 |
Anciens postes connus de Scott Sudduth
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| MODERNA, INC. | Corporate Officer/Principal | - |
Formation de Scott Sudduth
| Clarkson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
